Condition

Dermatomyositis

Treatments and trials tagged Dermatomyositis, with the same country and access zoom as New Developments.

All New Developments

Dermatomyositis breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited StatesCanada

New Daily Pill for Adult Muscle and Skin Inflammation

Lisraya (brepocitinib) — first oral TYK2/JAK1 tablet labelled for adult dermatomyositis

FDA labelled a once-daily 30 mg pill for dermatomyositis in adults (27 August 2026), with a boxed JAK-class…